The association of metastatic NNMT overexpression with lower DSS is in keeping with results from earlier studies reporting NNMT overexpression in the primary tumor to be a poor prognostic factor in gastric cancer [6], pancreatic cancer [7], and hepatocellular carcinoma [22]. The gene discussed is NNMT; the disease is neoplasm.